Abstract Background Inflammatory bowel disease (IBD) and psoriatic arthritis (PsA) are immune-mediated diseases (IMDs) that have been independently related to shifts in the gut microbiota. In this pilot study, we analyzed whether, in patients in whom both IMIDs coexist, the composition and function of the gut microbiota is different from when only one of the two IMDs exists. Methods Transversal observational study performed at a Spanish tertiary hospital. Ten patients with concomitant IBD and PsA (group A) were included. Two age, gender and disease duration matched control groups were also created, one with IBD-only patients (group B, n=20), and another with PsA-only patients (group C, n=20). Demographic and clinical characteristics were recorded. Stool samples were collected and the variable region V3–V4 of the bacterial 16S rRNA genes present in the feces was PCR-amplified and the resulting amplicons were sequenced on an Illumina NovaSeq 6000 instrument. Short chain fatty acids (SCFA) were analyzed by gas chromatography from the supernatants of the homogenized feces. Dietary assessment was registered by an online food frequency questionnaire specifically designed for intestinal disturbances; foods were transformed into nutrients and dietary compounds. For statistical analysis, ANOVA was used to compare the three groups (when the ANOVA was significant [p<0.05], Bonferroni's test was used for post-hoc comparisons). Results Globally, the microbiota of the different study groups did not show major rearrangements, with alpha diversity not showing statistically significant differences between them. However, beta diversity analyses indicated that the microbiotas of groups C and B were statistically different, with group A occupying an intermediate position. A linear discriminant analysis of the effect size showed that group A was enriched in certain microorganisms such as Akkermansia, while group C was enriched in Bacteroides (Figure 1). The quantification of the fecal levels of SCFA showed no statistical significant differences between the three groups. Moreover, no significant differences were observed regarding energy and nutrient intake between the assessed groups. Conclusion Our results suggest the existence of different gut microbiota profiles in subjects suffering from PsA or IDB, while patients with both conditions have an intermediate composition. These differences do not see to result from different dietary habits, since no differences in nutrient or energy intake between the groups were observed.
Read full abstract